Cargando…

Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity

Fatty acid (FA) metabolism is deregulated in several human diseases including metabolic syndrome, type 2 diabetes and cancers. Therefore, FA-metabolic enzymes are potential targets for drug therapy, although the consequence of these treatments must be precisely evaluated at the organismal and cellul...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, Damien, Rubin, Thomas, Poidevin, Mickael, Maroni, Brigitte, Le Rouzic, Arnaud, Parvy, Jean-Philippe, Montagne, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334898/
https://www.ncbi.nlm.nih.gov/pubmed/25692475
http://dx.doi.org/10.1371/journal.pgen.1004995
_version_ 1782358248577302528
author Garrido, Damien
Rubin, Thomas
Poidevin, Mickael
Maroni, Brigitte
Le Rouzic, Arnaud
Parvy, Jean-Philippe
Montagne, Jacques
author_facet Garrido, Damien
Rubin, Thomas
Poidevin, Mickael
Maroni, Brigitte
Le Rouzic, Arnaud
Parvy, Jean-Philippe
Montagne, Jacques
author_sort Garrido, Damien
collection PubMed
description Fatty acid (FA) metabolism is deregulated in several human diseases including metabolic syndrome, type 2 diabetes and cancers. Therefore, FA-metabolic enzymes are potential targets for drug therapy, although the consequence of these treatments must be precisely evaluated at the organismal and cellular levels. In healthy organism, synthesis of triacylglycerols (TAGs)—composed of three FA units esterified to a glycerol backbone—is increased in response to dietary sugar. Saturation in the storage and synthesis capacity of TAGs is associated with type 2 diabetes progression. Sugar toxicity likely depends on advanced-glycation-end-products (AGEs) that form through covalent bounding between amine groups and carbonyl groups of sugar or their derivatives α-oxoaldehydes. Methylglyoxal (MG) is a highly reactive α-oxoaldehyde that is derived from glycolysis through a non-enzymatic reaction. Glyoxalase 1 (Glo1) works to neutralize MG, reducing its deleterious effects. Here, we have used the power of Drosophila genetics to generate Fatty acid synthase (FASN) mutants, allowing us to investigate the consequence of this deficiency upon sugar-supplemented diets. We found that FASN mutants are lethal but can be rescued by an appropriate lipid diet. Rescued animals do not exhibit insulin resistance, are dramatically sensitive to dietary sugar and accumulate AGEs. We show that FASN and Glo1 cooperate at systemic and cell-autonomous levels to protect against sugar toxicity. We observed that the size of FASN mutant cells decreases as dietary sucrose increases. Genetic interactions at the cell-autonomous level, where glycolytic enzymes or Glo1 were manipulated in FASN mutant cells, revealed that this sugar-dependent size reduction is a direct consequence of MG-derived-AGE accumulation. In summary, our findings indicate that FASN is dispensable for cell growth if extracellular lipids are available. In contrast, FA-synthesis appears to be required to limit a cell-autonomous accumulation of MG-derived-AGEs, supporting the notion that MG is the most deleterious α-oxoaldehyde at the intracellular level.
format Online
Article
Text
id pubmed-4334898
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43348982015-02-24 Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity Garrido, Damien Rubin, Thomas Poidevin, Mickael Maroni, Brigitte Le Rouzic, Arnaud Parvy, Jean-Philippe Montagne, Jacques PLoS Genet Research Article Fatty acid (FA) metabolism is deregulated in several human diseases including metabolic syndrome, type 2 diabetes and cancers. Therefore, FA-metabolic enzymes are potential targets for drug therapy, although the consequence of these treatments must be precisely evaluated at the organismal and cellular levels. In healthy organism, synthesis of triacylglycerols (TAGs)—composed of three FA units esterified to a glycerol backbone—is increased in response to dietary sugar. Saturation in the storage and synthesis capacity of TAGs is associated with type 2 diabetes progression. Sugar toxicity likely depends on advanced-glycation-end-products (AGEs) that form through covalent bounding between amine groups and carbonyl groups of sugar or their derivatives α-oxoaldehydes. Methylglyoxal (MG) is a highly reactive α-oxoaldehyde that is derived from glycolysis through a non-enzymatic reaction. Glyoxalase 1 (Glo1) works to neutralize MG, reducing its deleterious effects. Here, we have used the power of Drosophila genetics to generate Fatty acid synthase (FASN) mutants, allowing us to investigate the consequence of this deficiency upon sugar-supplemented diets. We found that FASN mutants are lethal but can be rescued by an appropriate lipid diet. Rescued animals do not exhibit insulin resistance, are dramatically sensitive to dietary sugar and accumulate AGEs. We show that FASN and Glo1 cooperate at systemic and cell-autonomous levels to protect against sugar toxicity. We observed that the size of FASN mutant cells decreases as dietary sucrose increases. Genetic interactions at the cell-autonomous level, where glycolytic enzymes or Glo1 were manipulated in FASN mutant cells, revealed that this sugar-dependent size reduction is a direct consequence of MG-derived-AGE accumulation. In summary, our findings indicate that FASN is dispensable for cell growth if extracellular lipids are available. In contrast, FA-synthesis appears to be required to limit a cell-autonomous accumulation of MG-derived-AGEs, supporting the notion that MG is the most deleterious α-oxoaldehyde at the intracellular level. Public Library of Science 2015-02-18 /pmc/articles/PMC4334898/ /pubmed/25692475 http://dx.doi.org/10.1371/journal.pgen.1004995 Text en © 2015 Garrido et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Garrido, Damien
Rubin, Thomas
Poidevin, Mickael
Maroni, Brigitte
Le Rouzic, Arnaud
Parvy, Jean-Philippe
Montagne, Jacques
Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title_full Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title_fullStr Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title_full_unstemmed Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title_short Fatty Acid Synthase Cooperates with Glyoxalase 1 to Protect against Sugar Toxicity
title_sort fatty acid synthase cooperates with glyoxalase 1 to protect against sugar toxicity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334898/
https://www.ncbi.nlm.nih.gov/pubmed/25692475
http://dx.doi.org/10.1371/journal.pgen.1004995
work_keys_str_mv AT garridodamien fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT rubinthomas fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT poidevinmickael fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT maronibrigitte fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT lerouzicarnaud fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT parvyjeanphilippe fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity
AT montagnejacques fattyacidsynthasecooperateswithglyoxalase1toprotectagainstsugartoxicity